Labiotech

2 weeks ago | labiotech.eu | Jules Adam

Subscribe to our newsletter to get the latest biotech news!By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*PhoneThis field is for validation purposes and should be left unchanged. After a tough period of layoffs and hiring freezes, many were hoping 2025 would bring some relief to the biotech job market. But so far, that rebound hasn’t quite arrived.

2 weeks ago | labiotech.eu | Roohi Mariam Peter

Subscribe to our newsletter to get the latest biotech news!By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*CommentsThis field is for validation purposes and should be left unchanged. For decades, cystic fibrosis has remained a relentless, life-limiting disease. But now, the future of cystic fibrosis care could be shifting from symptom management to something far more revolutionary.

2 weeks ago | labiotech.eu | Jules Adam

Subscribe to our newsletter to get the latest biotech news!By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*CommentsThis field is for validation purposes and should be left unchanged. Do you associate biotech with space conquest? Space isn’t just about rockets and satellites – it’s an increasingly valuable environment for running biomedical experiments that aren’t possible on Earth.

3 weeks ago | labiotech.eu | Roohi Mariam Peter

Subscribe to our newsletter to get the latest biotech news!By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*PhoneThis field is for validation purposes and should be left unchanged. The month of March saw biopharmas accelerate drug development in the fields of small molecules, bispecific antibodies, and protein therapeutics, among others.

3 weeks ago | labiotech.eu | Ryoji Iwata |Jules Adam

Subscribe to our newsletter to get the latest biotech news!By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*EmailThis field is for validation purposes and should be left unchanged. Alzheimer’s disease affects more than 55 million people worldwide — a number expected to nearly triple by 2050.